US · guidance
CMS SOM App. L, Tag Q-0219
§416.50 Condition for Coverage - Patient Rights
The ASC must inform the patient or the patient’s representative or surrogate of the
patient’s rights and must protect and promote the exercise of these rights, as set
forth in this section. The ASC must also post the written notice of patient rights in a
place or places within the ASC likely to be noticed by patients waiting for treatment
or by the patient’s representative or surrogate, if applicable.
Interpretive Guidelines: §416.50
The ASC must inform each of its patients, or the patient’s representative or surrogate in
the case of minor patients or other situations where there is a designated representative
for the patient, of their rights as an ASC patient. Further, all of the ASC’s policies,
procedures and actions must be consistent with the protection of the patients’ rights
articulated in this Condition. Further, the ASC must actively promote the patient’s
exercise of their rights.
In addition, the ASC must ensure that the written notice of patient rights is posted in one
or more places where it is likely to be seen by patients waiting for treatment, or the
patient’s representative or surrogate, if applicable. Such areas include, but are not limited
to, waiting rooms or pre-operative preparation areas where patients are awaiting care.
Notices must be posted in at least one area. Whether the ASC must post more than one
notice depends on the size and physical layout of the areas where notices are posted. The
determining factor is whether the notice(s) are posted in a manner that all patients (or
their representatives or surrogates, as applicable) are likely to see the notice.
The patient’s representative or surrogate is an individual designated by the patient, in
accordance with applicable State law, to make health care decisions on behalf of the
individual or to otherwise assist the patient during his/her stay in the ASC. Designation
may be in writing, as in an advance directive or medical power of attorney, or may be
oral (verbal). Written designation may occur before the patient presents to the ASC, or
during the ASC registration process. Oral designation may take place at any time during
the patient’s visit in the ASC. The patient’s representative or surrogate includes, but is
not limited to, an individual who could be a family member or friend who accompanies
the patient. Depending on the designation the patient has made, the patient’s
representative or surrogate may make all health care decisions for the patient during
his/her ASC visit, or may act in a more limited role, for example, as a liaison between the
patient and the ASC to help the patient communicate, understand, remember, and cope
with the interactions that take place during the visit, and explain any instructions to the
patient that are delivered by the ASC staff. If a patient is unable to fully communicate
directly with the ASC staff, then the ASC may give patient rights information to the
patient’s representative or surrogate.
Survey Procedures: §416.50
When there is a team surveying the ASC, survey of the Patients’ Rights Condition should
be coordinated by one surveyor. However, each surveyor, as he or she conducts his/her
survey assignments, should assess the ASC’s compliance with the Patient’s Rights
regulatory requirements. It is particularly important for the surveyor who will be
following one or more patients from the start of their case to discharge to be observing
how the ASC’s actions protect and promote those patients’ exercise of their rights.
• Determine whether the ASC provides patients (or their representatives or
surrogates, as applicable), with notice of their rights, consistent with the standards
under this condition.
• Determine whether the ASC promotes the patients’ exercise of their rights (or
their representatives or surrogates, as applicable), consistent with the standards
under this condition.
Review posted notices to determine if they contain the same information as the individual
written notice provided to patients or their representatives/surrogates, as required under
§416.50(a). Deficiencies related to posting of the notice are to be cited using tag -Q0219.
History
Rev. 95, Issued: 12-12-13, Effective: 06-07-13, Implementation: 06-07-13
Provenance
- Source
- cms.gov
- Retrieved
- 2026-07-22
- Edition
- som-2026-07-22
- Content hash
9309e22a334b4d37a4f0535e142b9d0892e4155ed645180e511657ba214c7c2d
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.